Abbott Laboratories (NYSE:ABT) Is Maintained at Buy by Bank of America Securities.
Abbott Laboratories (NYSE:ABT) Is Maintained at Buy by Bank of America Securities Read Post »
UBS analyst Danielle Antalffy assumes Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price Target of $117.
UBS announced Abbott Laboratories (NYSE:ABT) Price Target of $117 Read Post »
UBS Downgrades Medtronic (NYSE:MDT) to Sell From Buy, Adjusts Price Target to $79 From $127
UBS Adjusts Medtronic (NYSE:MDT) Price Target to $79 From $127 Read Post »
Barclays analyst Steven Valiquette maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $110 to $100.
Barclays lowered CVS Health (NYSE:CVS) price target from $110 to $100 Read Post »
CVS Health Corp. (NYSE:CVS) now expects to close its acquisition of Oak Street Health Inc. in the first half of 2023.
CVS Health (NYSE:CVS) Expects to Close Oak Street Acquisition in 1H of 2023 Read Post »
The Cigna Group (NYSE:CI) updated its FY 2023 earnings guidance on Saturday. The company provided earnings per share (EPS) guidance of $24.60 for the period, compared to the consensus estimate of $24.77.
The Cigna Group (NYSE:CI) Releases FY 2023 Earnings Guidance Read Post »
Mizuho analyst Ann Hynes reiterates Cigna Group (NYSE:CI) with a Buy and maintains $360 price target.
Mizuho maintained Cigna Group (NYSE:CI) $360 price target Read Post »
Truist Securities analyst Tobey Sommer maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $610 to $580.
Truist Securities lowered Elevance Health (NYSE:ELV) price target from $610 to $580 Read Post »
RBC Capital analyst Ben Hendrix upgrades Elevance Health (NYSE:ELV) from Sector Perform to Outperform and raises the price target from $523 to $572.
RBC Capital Raised Elevance Health (NYSE:ELV) target price to $572.00 Read Post »
Wells Fargo & Company Trims Centene (NYSE:CNC) Target Price to $71.00 from $79.00 with an equalweight rating
Wells Fargo & Company Trims Centene (NYSE:CNC) Target Price to $71.00 Read Post »
Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $325 price target.
Needham Reiterates Buy on Biogen (NASDAQ:BIIB) , Maintains $325 Price Target Read Post »
CVS Health (NYSE:CVS) Keeps Quarterly Dividend at $0.605 a Share, Payable May 1 to Holders of Record April 21
CVS Health (NYSE:CVS) Keeps Quarterly Dividend at $0.605 a Share Read Post »